Search

Venkataraman Balasubramanian

Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1624, 1611
Total Applications
2999
Issued Applications
2017
Pending Applications
254
Abandoned Applications
728

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 377105 [patent_doc_number] => 07312205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Methods and compositions for inhibiting tumor growth' [patent_app_type] => utility [patent_app_number] => 10/545143 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3324 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312205.pdf [firstpage_image] =>[orig_patent_app_number] => 10545143 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545143
Methods and compositions for inhibiting tumor growth Feb 10, 2004 Issued
Array ( [id] => 7034250 [patent_doc_number] => 20050032760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Continuous process for the production of r-rofleponide' [patent_app_type] => utility [patent_app_number] => 10/495692 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2609 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032760.pdf [firstpage_image] =>[orig_patent_app_number] => 10495692 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/495692
Continuous process for the production of r-rofleponide Feb 8, 2004 Abandoned
Array ( [id] => 7152128 [patent_doc_number] => 20040171853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Microbial process to prepare5-androsten-3beta,7alpha, 15alpha-triol-17-one and related analogues' [patent_app_type] => new [patent_app_number] => 10/772527 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2679 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171853.pdf [firstpage_image] =>[orig_patent_app_number] => 10772527 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/772527
Microbial process to prepare5-androsten-3beta,7alpha, 15alpha-triol-17-one and related analogues Feb 4, 2004 Abandoned
Array ( [id] => 7378049 [patent_doc_number] => 20040220154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Topical testosterone formulations and associated methods' [patent_app_type] => new [patent_app_number] => 10/765003 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17410 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220154.pdf [firstpage_image] =>[orig_patent_app_number] => 10765003 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/765003
Topical testosterone formulations and associated methods Jan 25, 2004 Abandoned
Array ( [id] => 7378090 [patent_doc_number] => 20040220160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Topical testosterone formulations and associated methods' [patent_app_type] => new [patent_app_number] => 10/765004 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17410 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220160.pdf [firstpage_image] =>[orig_patent_app_number] => 10765004 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/765004
Topical testosterone formulations and associated methods Jan 25, 2004 Abandoned
Array ( [id] => 5835620 [patent_doc_number] => 20060247452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Method for obtaining 17sg(a)-acetoxy-11$g(b)-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione' [patent_app_type] => utility [patent_app_number] => 10/542821 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4217 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247452.pdf [firstpage_image] =>[orig_patent_app_number] => 10542821 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/542821
Method for obtaining 17sg(a)-acetoxy-11$g(b)-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione Jan 20, 2004 Abandoned
Array ( [id] => 7677152 [patent_doc_number] => 20040152674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Pharmaceutically active compounds and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/762081 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12955 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152674.pdf [firstpage_image] =>[orig_patent_app_number] => 10762081 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/762081
Pharmaceutically active compounds and methods of use thereof Jan 19, 2004 Abandoned
Array ( [id] => 92260 [patent_doc_number] => 07732432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => '17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/540757 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9572 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732432.pdf [firstpage_image] =>[orig_patent_app_number] => 10540757 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/540757
17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators Jan 15, 2004 Issued
Array ( [id] => 7255715 [patent_doc_number] => 20050075379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis' [patent_app_type] => utility [patent_app_number] => 10/759617 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13456 [patent_no_of_claims] => 260 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075379.pdf [firstpage_image] =>[orig_patent_app_number] => 10759617 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/759617
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis Jan 15, 2004 Issued
Array ( [id] => 7152040 [patent_doc_number] => 20040171839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Polycyclic aryl and heteroaryl substituted 1, 4-quinones useful for selective inhibition of the coagulation cascade' [patent_app_type] => new [patent_app_number] => 10/753213 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64647 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171839.pdf [firstpage_image] =>[orig_patent_app_number] => 10753213 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/753213
Polycyclic aryl and heteroaryl substituted 1, 4-quinones useful for selective inhibition of the coagulation cascade Jan 6, 2004 Abandoned
Array ( [id] => 7297216 [patent_doc_number] => 20040214769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Estrogen receptors' [patent_app_type] => new [patent_app_number] => 10/752146 [patent_app_country] => US [patent_app_date] => 2004-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7743 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214769.pdf [firstpage_image] =>[orig_patent_app_number] => 10752146 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/752146
Estrogen receptors Jan 5, 2004 Abandoned
Array ( [id] => 7151249 [patent_doc_number] => 20040171657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Microbicidal active substances' [patent_app_type] => new [patent_app_number] => 10/750810 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4582 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171657.pdf [firstpage_image] =>[orig_patent_app_number] => 10750810 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/750810
Microbicidal active substances Dec 30, 2003 Abandoned
Array ( [id] => 7326203 [patent_doc_number] => 20040138486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Process improvements in steroid chemistry' [patent_app_type] => new [patent_app_number] => 10/744857 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9272 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138486.pdf [firstpage_image] =>[orig_patent_app_number] => 10744857 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/744857
Process improvements in steroid chemistry Dec 21, 2003 Issued
Array ( [id] => 7378100 [patent_doc_number] => 20040220161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Pharmaceutical compositions and treatment methods-6' [patent_app_type] => new [patent_app_number] => 10/741929 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 111997 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220161.pdf [firstpage_image] =>[orig_patent_app_number] => 10741929 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/741929
Pharmaceutical compositions and treatment methods-6 Dec 18, 2003 Abandoned
Array ( [id] => 6972292 [patent_doc_number] => 20050038002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Substituted tetracycline compounds' [patent_app_type] => utility [patent_app_number] => 10/740961 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25414 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038002.pdf [firstpage_image] =>[orig_patent_app_number] => 10740961 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/740961
Substituted tetracycline compounds Dec 17, 2003 Issued
Array ( [id] => 5614431 [patent_doc_number] => 20060116359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => '17.Beta-(alpha-hydroxy)-esters of androstanes as intermediates for the preparation of 17.beta-fluorinated-androstane esters' [patent_app_type] => utility [patent_app_number] => 10/538083 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11878 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116359.pdf [firstpage_image] =>[orig_patent_app_number] => 10538083 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/538083
17.Beta-(alpha-hydroxy)-esters of androstanes as intermediates for the preparation of 17.beta-fluorinated-androstane esters Dec 17, 2003 Abandoned
Array ( [id] => 7740619 [patent_doc_number] => 08106035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => '25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3' [patent_app_type] => utility [patent_app_number] => 10/738248 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 12 [patent_no_of_words] => 42105 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106035.pdf [firstpage_image] =>[orig_patent_app_number] => 10738248 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/738248
25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3 Dec 17, 2003 Issued
Array ( [id] => 132865 [patent_doc_number] => 07696186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => '7,9-substituted tetracycline compounds' [patent_app_type] => utility [patent_app_number] => 10/738862 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10156 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696186.pdf [firstpage_image] =>[orig_patent_app_number] => 10738862 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/738862
7,9-substituted tetracycline compounds Dec 15, 2003 Issued
Array ( [id] => 7310801 [patent_doc_number] => 20040142995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups' [patent_app_type] => new [patent_app_number] => 10/734630 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10597 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142995.pdf [firstpage_image] =>[orig_patent_app_number] => 10734630 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/734630
Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups Dec 11, 2003 Issued
Array ( [id] => 7672910 [patent_doc_number] => 20040180869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'New glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility' [patent_app_type] => new [patent_app_number] => 10/735487 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5250 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180869.pdf [firstpage_image] =>[orig_patent_app_number] => 10735487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/735487
Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility Dec 11, 2003 Issued
Menu